UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
18.88
0.08 (0.43%)
At close: Sep 05, 2025, 3:59 PM
19.28
2.12%
After-hours: Sep 05, 2025, 06:28 PM EDT
UroGen Pharma Revenue
UroGen Pharma reported an annual revenue of $90.4M, reflecting a 9.29% growth. For the quarter ending June 30, 2025, UroGen Pharma generated $24.21M in revenue.
Revenue (ttm)
90.4M
Revenue Growth
9.29%
Price / Sales Ratio
5.05
Revenue / Employee
386.32K
Employees
234
Market Cap
873.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 90.4M | +9.29% |
| Dec 31, 2023 | 82.71M | +28.52% |
| Dec 31, 2022 | 64.36M | +33.96% |
| Dec 31, 2021 | 48.04M | +307.17% |
| Dec 31, 2020 | 11.8M | +65450.00% |
| Dec 31, 2019 | 18K | -98.40% |
| Dec 31, 2018 | 1.13M | -86.17% |
| Dec 31, 2017 | 8.16M | -53.46% |
| Dec 31, 2016 | 17.53M | +Infinity% |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |